BBNX Financials
Beta Bionics, Inc. Common Stock - Financial statements & key metrics
Stock Price
$19.07
Market Cap
$640.80M
P/E Ratio
-2.2
EPS
$-1.94
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$65.12M
Gross Profit
-
Operating Income
-
Net Income
$-54.76M
EPS (Diluted)
$-8.60
Balance Sheet Highlights
Total Assets
$149.65M
Total Liabilities
$73.63M
Shareholders Equity
-
Cash & Equivalents
$30.43M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-48.27M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-62.5%
Net Margin
-87.9%
ROE
-47.5%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is BBNX revenue?
BBNX's most recent quarterly revenue was $65.12M. Annual revenue can be calculated by summing the four most recent quarters.
Is BBNX profitable?
BBNX reported a loss of $54.76M in the most recent quarter. The net profit margin is -87.9%.
What is BBNX market cap?
BBNX has a market capitalization of $640.80M, making it a small-cap stock.
Does BBNX have debt?
View BBNX's balance sheet for debt information.
What is BBNX cash flow?
Cash flow data is available in the full financial statements.